Research progress on the role of platelet-derived microparticles in the development of atherosclerosis

Abstract

Abstract: Platelet-derived microparticles(PMPs) are extremely small vesicles with complex structure and composition released by platelets, which contain proteins, mRNAs, miRNAs and other bioactive substances and participate in various pathophysiological processes. PMPs promote the development of atherosclerosis(AS) by participating in the processes of vascular endothelial cell injury, inflammatory reaction, lipoprotein deposition, macrophage phagocytosis and plaque instability. Anti-platelet drugs can lower down the plasma level of PMPs. Therefore, PMPs provide a new perspective for the explanation of the pathogenesis and treatment of cardiovascular diseases.

Key words: platelet-derived microparticles, atherosclerosis, endothelial cells, inflammatory reaction

CLC Number:

R541.4

GUO Fang-jun, YANG Ren-qiang. Research progress on the role of platelet-derived microparticles in the development of atherosclerosis[J]. Basic & Clinical Medicine, 2020, 40(11): 1551-1555.

References

[1] Uveges A, Jenei C, Kiss T, et al. Three-dimensional evaluation of the spatial morphology of stented coronary artery segments in relation to restenosis[J]. Int J Cardiovasc Imaging, 2019, 35: 1755-1763.
[2] Alarcon M. Generation of platelet-derived microparticles through the activation of the toll-like receptor 4[J]. Heliyon, 2019, 5: e01486. doi: 10.1016/j.heliyon.2019.e01486.
[3] De Paoli SH, Tegegn TZ, Elhelu OK, et al. Dissecting the biochemical architecture and morphological release pathways of the human platelet extracellular vesiculome[J]. Cell Mol Life Sci, 2018, 75: 3781-3801.
[4] Ponomareva AA, Nevzorova TA, Mordakhanova ER, et al. Intracellular origin and ultrastructure of platelet-deri-ved microparticles[J]. J Thromb Haemost, 2017, 15: 1655-1667.
[5] Anene C, Graham AM, Boyne J, et al. Platelet microparticle delivered microRNA-Let-7a promotes the angiogenic switch[J]. Biochim Biophys Acta Mol Basis Dis, 2018, 1864: 2633-2643.
[6] Mortberg J, Lundwall K, Mobarrez F, et al. Increased concentrations of platelet-and endothelial-derived microparticles in patients with myocardial infarction and reduced renal function-a descriptive study[J]. BMC Nephrol, 2019, 20: 71. doi: 10.1186/s12882-019-1261-x.
[7] Gomes J, Lucien F, Cooper TT, et al. Analytical considerations in nanoscale flow cytometry of extracellular vesi-cles to achieve data linearity[J]. Thromb Haemost, 2018, 118: 1612-1624.
[8] Nielsen T, Kristensen SR, Gregersen H, et al. Extracellular vesicle-associated procoagulant phospholipid and tissue factor activity in multiple myeloma[J]. PLoS One, 2019, 14: e0210835. doi: 10.1371/journal.pone.0210835.
[9] Onodi Z, Pelyhe C, Terezia Nagy C, et al. Isolation of high-purity extracellular vesicles by the combination of iodixanol density gradient ultracentrifugation and bind-elute chromatography from blood plasma[J]. Front Physiol, 2018, 9: 1479. doi: 10.3389/fphys.2018.01479.
[10] Zacharia E, Antonopoulos AS, Oikonomou E, et al. Plasma signature of apoptotic microvesicles is associated with endothelial dysfunction and plaque rupture in acute coronary syndromes[J]. J Mol Cell Cardiol, 2020, 138: 110-114.
[11] Wang GH, Ma KL, Zhang Y, et al. Platelet micro-particles contribute to aortic vascular endothelial injury in diabetes via the mTORC1 pathway[J]. Acta Pharmacol Sin, 2019, 40: 468-476.
[12] Kong L, Li K, Gao L, et al. Mediating effects of platelet-derived extracellular vesicles on PM2.5-induced vascular endothelial injury[J]. Ecotoxicol Environ Saf, 2020, 198: 110652. doi: 10.1016/j.ecoenv.2020.110652.
[13] Kuravi SJ, Harrison P, Rainger GE, et al. Ability of platelet-derived extracellular vesicles to promote neutrophil-endothelial cell interactions[J]. Inflammation, 2019, 42: 290-305.
[14] Vajen T, Benedikter BJ, Heinzmann ACA, et al. Platelet extracellular vesicles induce a pro-inflammatory smooth muscle cell phenotype[J]. J Extracell Vesicles, 2017, 6: 1322454. doi: 10.1080/20013078.2017.1322454.
[15] Chatterjee M, Rath D, Schlotterbeck J, et al. Regulation of oxidized platelet lipidome: implications for coronary artery disease[J]. Eur Heart J, 2017, 38: 1993-2005.
[16] Diehl P, Nienaber F, Zaldivia MTK, et al. Lysophosphatidylcholine is a major component of platelet microvesicles promoting platelet activation and reporting atherosclerotic plaque instability[J]. Thromb Haemost, 2019, 119: 1295-1310.
[17] Vasina EM, Cauwenberghs S, Feijge MA, et al. Microparticles from apoptotic platelets promote resident macrophage differentiation[J]. Cell Death Dis, 2011, 2: e211. doi: 10.1038/cddis.2011.94.
[18] Feng C, Chen Q, Fan M, et al. Platelet-derived microparticles promote phagocytosis of oxidized low-density lipoprotein by macrophages, potentially enhancing foam cell formation[J]. Ann Transl Med, 2019, 7: 477. doi: 10.21037/atm.2019.08.06.
[19] Laffont B, Corduan A, Rousseau M, et al. Platelet microparticles reprogram macrophage gene expression and function[J]. Thromb Haemost, 2016, 115: 311-323.
[20] 汪泽扬, 潘丽娜, 陈丽媛,等. 血小板微粒对ApoE~(-/-)小鼠动脉粥样硬化斑块形成及稳定性的影响[J]. 第三军医大学学报, 2019, 41: 514-520.
[21] Recabarren-Leiva D, Alarcon M. Standardization of a fast and effective method for the generation and detection of platelet-derived microparticles by a flow cytometer[J]. Immunol Lett, 2018, 194: 79-84.
[22] Geng XY, Xiao N, Han Y, et al. Platelet microparticles: A tool to predict infarction area in rats[J]. J Invest Surg, 2019, 1-6. doi: 10.1080/08941939.2019.1606369.
[23] Rosinska J, Ambrosius W, Maciejewska J, et al. Association of platelet-derived microvesicles and their phenotypes with carotid atherosclerosis and recurrent vascular events in patients after ischemic stroke[J]. Thromb Res, 2019, 176: 18-26.
[24] Xue LJ, Cui BB, Li X, et al. Association of elevated platelet microparticles with disease activity in rheumatoid arthritis[J]. J Sichuan University(Medicial Science Edition), 2017, 48: 405-409.
[25] Miao D, Ma TT, Chen M, et al. Platelets release proinflammatory microparticles in anti-neutrophil cytoplasmic antibody-associated vasculitis[J]. Rheumatology (Oxford), 2019, doi: 10.1093/rheumatology/kez044.